The deal for Intersect, a data center and energy developer, is set to help Google build out its infrastructure for artificial intelligence. By Eli Tan Reporting from Seattle Google has agreed to buy ...
Structure Therapeutics (GPCR) just moved its obesity pipeline up a gear by kicking off a first in human Phase 1 trial for ACCG-2671, its oral amylin receptor agonist targeting metabolic disease. See ...
Highlight your research and enhance its visibility to your field and community by submitting a data descriptor to one of our Collections. Characterisation and performance data of energy materials This ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback